Posted On: 04/05/2013 9:17:49 AM
Post# of 102338
$BMSN Cornering a 4.8 Billion Dollar Mkt!!!
"will allow us to expand into the larger market of blood production disorders which exceeds $4.84 billion per year and currently addressed by growth factors such as Neupogen®, Neulasta®, Leukine® and Revolade®."
http://finance.yahoo.com/news/bio-matrix-scie...00215.html
(0)
(0)Scroll down for more posts ▼
